Abstract
The concentration of cyclosporine in the aqueous and vitreous humors of albino rabbits was measured, using HPLC at intervals of 24, 48, 96, and 192 hours after subconjunctival injections of 2.5 mg of free or liposome-bound cyclosporine. The aqueous concentration was reasonably high in both groups until day 4: 1050 nanograms per milliliter in the group receiving free cyclosporine, and 1438 nanograms per milliliter in the group receiving liposome-bound cyclosporine. The vitreous concentration was very low in both groups.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abel R, Boyle GH. Dissecting ocular tissue for intraocular drug studies. Invest Ophthalmol Vis Sci 1976; 25: 216–19.
Bell TAG, Easty DL, McCullagh KG. A placebo controlled blind trial of cyclosporin A in prevention of corneal graft rejection in rabbits. Br J Ophthalmol 1982; 66: 303–08.
Bell TAG, Hunnisett AG. Cyclosporin A: tissue levels following topical and systemic administration to rabbits. Br J Ophthalmol 1986; 70: 852–55.
Bio-Rad instruction manual: Cyclosporin by HPLC test. September, 1986.
Borel JF, Feurer C, Gubler HU, Stahelin H. Biological effects of cyclosporin A: a new antilymphotic agent. Agents in Action 1976; 6: 468–75.
Coster DJ, Shepard WFI, Chin Fook T et al. Prolonged survival of corneal allografts in rabbits treated with cyclosporin A. Lancet 1979; ii: 688–89.
Hunter PA, Wilhelmus KR, Rice NSC et al. Cyclosporin A applied topically to the recipient eye inhibits corneal graft rejection. Clin Exp Immunol 1981; 45: 173–77.
Kana JS, Hoffman F, Buchen R et al. Rabbit corneal allograft survival following topical administration of cyclosporin A. Invest Ophthalmol Vis Sci 1982; 22: 686–90.
Magin RL, Niesman MR. Temperature dependent permeability of large unilamellar liposomes. Chem Phys Lipids 1984; 34: 245–56.
Magin RL, Weinstein JN, In: Gregoriadis G, ed. Liposomes technology. Boca Raton, Florida: CRC Press, 1983.
Mosteller WM, Gebhardt BM, Hamilton AM, Kaufman HE. Penetration of topical cyclosporine into the rabbit cornea aqueous humor, and serum. Arch Ophthalmol 1985; 103: 101–02.
Nussenblatt RB, Dinning WJ, Jujikawa HS et al. Local cyclosporin therapy experimental autoimmune uveitis in rats. Arch Ophthalmol 1985; 103: 1559–62.
Nussenblatt RB, Palestine AG. Cyclosporin, immunology, pharmacology, and therapeutic uses. Surv Ophthalmol 1986; 31: 159–69.
Palestine AG, Nussenblatt RB, Chan C-C. Cyclosporin penetration into the anterior chamber and cerebral spinal fluid. Am J Ophthalmol 1985; 99: 210–11.
Rousel TJ, Osato MS, Wilhelmus KR. Cyclosporine and experimental corneal transplantation. Transplnt Proc (Suppl) 1983; 15: 3081–83.
Salisbury JD, Gebhardt BM. Suppression of corneal allograft rejection by cyclosporin A. Arch Ophthalmol 1981; 99: 1640–43.
Szoka F, Paphadjopoulos D. Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse phase evaporation. Proc Natl Acad Sci USA 1978; 75: 4194.
Widerholt M, Kossendrup D, Schulz W, Hoffman F. Pharmacokinetic of topical cyclosporin A in rabbit eye. Invest Ophthalmol Vis Sci 1986; 27: 519–24.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Alghadyan, A.A., Peyman, G.A., Khoobehi, B. et al. Liposome-bound cyclosporine: Aqueous and vitreous level after subconjunctival injection. Int Ophthalmol 12, 101–104 (1988). https://doi.org/10.1007/BF00137133
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00137133